spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Colorectal Cancer 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 3 Jan 2023
ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Mar 2022
First U.S. trial using GI Genius(TM) intelligent endoscopy module shows 50% reduction in missed colorectal polyps with artificial intelligence (AI) technology versus standard colonoscopy
Devices Gastroenterology
 HSMN NewsFeed - 9 Feb 2022
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres(R) Y-90 resin microspheres in China from the National Medical Products Administration
Devices Oncology Regulatory
 HSMN NewsFeed - 7 Feb 2022
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan
Devices Gastroenterology Oncology FDA
 HSMN NewsFeed - 22 Nov 2021
Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan(R)
Devices Gastroenterology Oncology
 HSMN NewsFeed - 16 Nov 2021
Geneoscopy Closes $105M in Financing to Advance its Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention
Diagnostics Venture Capital
 HSMN NewsFeed - 11 Oct 2021
Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres(R) Y-90 resin microspheres in China
Devices Oncology
 HSMN NewsFeed - 16 Sep 2021
LUMAKRAS(TM) (Sotorasib) Combined With Vectibix(R) (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 12 Jul 2021
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 May 2021
Modeling Data Showed Cologuard(R) Was Superior to Fecal Immunochemical Test (FIT) on Cost Effectiveness and Colorectal Cancer Incidence and Mortality
Diagnostics Oncology
 HSMN NewsFeed - 12 Apr 2021
U.S. FDA Grants De Novo Clearance for First and Only Artificial Intelligence System for Colonoscopy; Medtronic Launches GI Genius(TM) Intelligent Endoscopy Module
Devices Gastroenterology FDA Product Launch
 HSMN NewsFeed - 12 Apr 2021
Cosmo announces FDA approval of GI Genius(TM) intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy
Devices Gastroenterology FDA
 HSMN NewsFeed - 22 Mar 2021
Sirtex Medical announces new SIR-Spheres(R) DOORwaY-90 Study: The first prospective multicenter U.S.-based trial for registration as first-line treatment for hepatocellular carcinoma
Devices Oncology
 HSMN NewsFeed - 15 Mar 2021
Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan(R)
Devices Gastroenterology FDA
 HSMN NewsFeed - 23 Feb 2021
Elicio Therapeutics Announces FDA Clearance of IND application for ELI-002-- A Therapeutic Vaccine Targeting mutated KRAS Cancers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Feb 2021
Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2021
Sebela Pharmaceuticals Announces U.S. Launch of SUTAB(R) Tablets, An Alternative to Liquid Colonoscopy Preparation
Biopharmaceuticals Gastroenterology FDA Product Launch
 HSMN NewsFeed - 8 Dec 2020
Amgen's Sotorasib Granted Breakthrough Therapy Designation for Advanced or Metastatic Non-Small Cell Lung Cancer Patients with KRAS G12C Mutation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Oct 2020
Exact Sciences and Pfizer Extend and Amend Cologuard(R) Promotion Agreement
Diagnostics Oncology
 HSMN NewsFeed - 14 Jul 2020
GI Supply Gets FDA Clearance of First Submucosal Lifting Agent in a Pre-filled 5mL Syringe
Devices Gastroenterology FDA
 HSMN NewsFeed - 1 Jul 2020
Sumitomo Dainippon Pharma Oncology Announces Its Formation Through Merger of Tolero and Boston Biomedical
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Jun 2020
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 May 2020
Cardiff Oncology Announces Fast Track Designation Granted by the FDA to Onvansertib for Second-Line Treatment of KRAS-Mutated Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2020
Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 25 Mar 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 9 Mar 2020
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Feb 2020
Ichnos Expands Leadership Team With Appointment Of Gabriela Gruia, M.D. As Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Dec 2019
Check-Cap Announces Positive Results from U.S. Pilot Study of C-Scan(R) System
Devices Gastroenterology
 HSMN NewsFeed - 11 Nov 2019
AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system
Devices Gastroenterology FDA
 HSMN NewsFeed - 5 Nov 2019
Regeneron Provides Updates on Phase 3 Libtayo(R) (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Oct 2019
Exact Sciences And Mayo Clinic Initiate 150,000 Patient, 7-Year Study To Evaluate Real-World Impact Of Cologuard(R)
Diagnostics Oncology Gastroenterology
 HSMN NewsFeed - 23 Sep 2019
Cologuard(R) Gains FDA Approval For Use In Younger Americans, Ages 45 To 49
Diagnostics Oncology FDA
 HSMN NewsFeed - 10 Sep 2019
Cologuard(R) Helps More People Get Screened In A Cost-Effective Way
Diagnostics Oncology
 HSMN NewsFeed - 3 Sep 2019
Laboratory for Advanced Medicine Receives FDA Breakthrough Device Designation for Liquid Biopsy Liver Cancer Detection Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 19 Aug 2019
Check-Cap and GE Healthcare Announce Completion of Manufacturing Line Transfer Implementation and Qualification for the C-Scan(R) System Operated by GE Healthcare
Devices Diagnostics Gastroenterology
 HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jul 2019
SurgiMab Advances SGM-101, a Novel Fluorescent Tumor-specific Antibody, Into Pivotal Phase 3 Clinical Trial to Improve Surgical Outcomes in Colorectal Cancer Patients
Diagnostics Oncology Surgery
 HSMN NewsFeed - 9 Jul 2019
Check-Cap Announces Positive Final Results from Its Post-CE Approval Study of the C-Scan(R) System
Devices Diagnostics Gastroenterology Oncology
 HSMN NewsFeed - 17 Jun 2019
Pfizer to Acquire Array BioPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Jun 2019
Check-Cap Appoints Joshua (Shuki) Belkar as Vice President of Operations
Devices Gastroenterology Oncology Personnel
 HSMN NewsFeed - 17 May 2019
Exact Sciences Presents New Data Reinforcing Performance of Cologuard(R)
Diagnostics Gastroenterology Oncology
 HSMN NewsFeed - 13 May 2019
Check-Cap Announces Second Trial Site Joins Ongoing U.S. Pilot Study of C-Scan(R)
Devices Gastroenterology
 HSMN NewsFeed - 8 May 2019
Daiichi Sankyo Announces [Fam-] Trastuzumab Deruxtecan Demonstrated Clinically Meaningful Response in Patients with Refractory HER2 Positive Metastatic Breast Cancer, a Population with High Unmet Need
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Feb 2019
Cologuard Helps Screen Two Million People for Colorectal Cancer
Diagnostics Oncology
 HSMN NewsFeed - 25 Feb 2019
FDA Approves Taiho Oncology's LONSURF(R) (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Feb 2019
Check-Cap Announces Institutional Review Board Approval to Initiate U.S. Pilot Study of C-Scan(R)
Devices Gastroenterology Radiology
 HSMN NewsFeed - 14 Jan 2019
Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] Trastuzumab Deruxtecan (DS-8201) in HER2 Low Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jan 2019
Clinical Genomics Appoints Betsy Hanna CEO
Diagnostics Oncology Personnel
 HSMN NewsFeed - 23 Nov 2018
Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore
Diagnostics Oncology
 HSMN NewsFeed - 5 Sep 2018
Check-Cap Receives Approval From the Israeli Ministry of Health to Initiate Commercial Sales in Israel of its C-Scan(R) System
Devices Diagnostics Gastroenterology Oncology Regulatory
 HSMN NewsFeed - 22 Aug 2018
Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard(R)
Diagnostics Oncology
 HSMN NewsFeed - 7 Aug 2018
Array BioPharma Receives FDA Breakthrough Therapy Designation for BRAFTOVI(TM) in combination with MEKTOVI(R) and cetuximab for BRAFV600E-mutant Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Jul 2018
The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI(TM) (encorafenib) in Combination with MEKTOVI(R) (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2018
PENTAX Medical Announces U.S. Deal To Distribute Third Eye(R) Panoramic(TM) Imaging System For Colon Cancer Screening
Devices Gastroenterology Oncology Distribution
 HSMN NewsFeed - 30 May 2018
Circulating Tumor Cells To Help Stage Metastatic Breast Cancer, New Research To Be Featured at ASCO Annual Meeting
Diagnostics Oncology
 HSMN NewsFeed - 7 May 2018
Salix Receives FDA Approval For PLENVU(R), Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies
Biopharmaceuticals Radiology Gastroenterology FDA
 HSMN NewsFeed - 11 Apr 2018
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 20 Mar 2018
Mark Stenhouse to join Exact Sciences as President, Cologuard
Diagnostics Oncology Personnel
 HSMN NewsFeed - 26 Feb 2018
Check-Cap Appoints Alex Ovadia as Chief Executive Officer
Devices Gastroenterology Personnel
 HSMN NewsFeed - 13 Feb 2018
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2018
Ferring's CLENPIQ(TM) (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Now Available
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 18 Jan 2018
Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 10 Jan 2018
Check-Cap Receives CE Mark Approval for C-Scan(R)
Devices Gastroenterology Radiology Oncology Regulatory
 HSMN NewsFeed - 27 Dec 2017
Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron's Petition to Rehear the Panel's Decision Affirming Merus' Inequitable Conduct Claim Against Regeneron
Biopharmaceuticals Oncology Litigation
 HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Sep 2017
Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Sep 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for TAGITOL(TM) V (Barium Sulfate) Oral Suspension
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 11 Sep 2017
Oncolytics Biotech(R) Announces the Presentation of REOLYSIN(R) Clinical Data at ESMO 2017 Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Sep 2017
Biocept Launches Liquid Biopsy Test for NRAS Mutations
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 29 Aug 2017
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 28 Aug 2017
Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Jul 2017
eFFECTOR Therapeutics Completes $38.6 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 3 Jul 2017
New Analysis Reveals First-Line Treatment Data on SIR-Spheres(R) Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
Devices Oncology
 HSMN NewsFeed - 31 May 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA(R) (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2017
Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 30 May 2017
Check-Cap Ltd. Announces $2.69 Million Financing
Devices Diagnostics Radiology Oncology Venture Capital
 HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 May 2017
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 27 Apr 2017
Cologuard Growth Accelerates to $48.4 Million in Revenue During First Quarter; Volume Grows 150 Percent Year Over Year to 100,000 Completed Tests
Diagnostics Oncology
 HSMN NewsFeed - 24 Apr 2017
SIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
Devices Oncology
 HSMN NewsFeed - 17 Apr 2017
OncoMed’s Phase 2 Trial of Tarextumab in Small Cell Lung Cancer Does Not Meet Endpoints
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Mar 2017
Bracco Diagnostics Inc. announces the launch of the PROTOCO2L TOUCH(R) Colon Insufflator for use in CT Colonography procedures
Devices Radiology Oncology Product Launch
 HSMN NewsFeed - 23 Mar 2017
GE Healthcare to Offer a More Comfortable Mammography Experience
Devices Radiology Product Launch
 HSMN NewsFeed - 9 Mar 2017
iCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System
Devices Oncology
 HSMN NewsFeed - 20 Feb 2017
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 9 Jan 2017
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 18 Nov 2016
Athenex and Lilly Enter Clinical Collaboration Agreement
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Nov 2016
Marina Biotech Announces Merger with IthenaPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Nov 2016
Boston Scientific Announces Acquisition Of The LumenR(TM) Tissue Retractor System
Devices Surgery Acquisitions
 HSMN NewsFeed - 19 Oct 2016
First Patient in Malaysia Receives TheraSphere(TM) Radioembolization Therapy
Devices Oncology
 HSMN NewsFeed - 11 Oct 2016
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of Intrahepatic Cholangiocarcinoma (iCCA)
Devices Oncology
 HSMN NewsFeed - 26 Sep 2016
MOTUS GI(TM) Receives FDA Clearance to Market the Pure-Vu(TM) System for Cleansing Poorly Prepared Colons During Colonoscopy
Devices Gastroenterology Oncology FDA
 HSMN NewsFeed - 20 Sep 2016
GI View Ltd. Receives FDA 510(k) Clearance for the New Aer-O-Scope(R) Disposable Colonoscope System with Working Channels for Therapeutic Intervention During Colorectal Cancer Screening
Devices Oncology FDA
 HSMN NewsFeed - 25 Aug 2016
Sirtex Medical Inc. Announces 19 Percent Dose Sales Growth of SIR-Spheres(R) Y-90 resin microspheres in Fiscal Year 2016
Devices Oncology
 HSMN NewsFeed - 5 Aug 2016
Virtual Colonoscopy Receives Highest Grade in the New U.S. Preventive Services Task Force Recommendation for Colorectal Cancer Screening
Devices Diagnostics Oncology
 HSMN NewsFeed - 26 Jul 2016
Exact Sciences Completes 54,000 Cologuard Tests during the Second Quarter
Diagnostics Oncology
 HSMN NewsFeed - 26 Jul 2016
CellMax Life Raises $14M in Venture Funding, Launches Precision Cancer Testing Company for Early Detection & Optimal Management of Cancer
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 1 Jul 2016
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres(R) Y-90 resin microspheres, New SIRFLOX Analysis Shows
Devices Oncology
 HSMN NewsFeed - 6 Jun 2016
Celator Pharmaceuticals(R) Presented Phase 3 Trial Results in Patients with High-Risk Acute Myeloid Leukemia Demonstrating VYXEOS(TM) (CPX-351) Significantly Improved Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2016
Exact Sciences Appoints Jeff Elliott to Lead Business Development & Strategy
Diagnostics Personnel
 HSMN NewsFeed - 31 May 2016
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 3 May 2016
XBiotech Appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 May 2016
Exact Sciences Completes 40,000 Cologuard Tests during First Quarter 2016
Diagnostics Oncology
 HSMN NewsFeed - 25 Apr 2016
Celator(R) Pharmaceuticals Announces Positive Results Demonstrating Reduced Healthcare Resource Use with VYXEOS(TM) Compared to Standard Treatment for Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Apr 2016
John Lapré to Fulfill Role as Elekta’s Chief Technology Officer
Devices Oncology Neurosurgery Personnel
 HSMN NewsFeed - 7 Apr 2016
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 4 Apr 2016
European Medicines Agency Grants Accelerated Assessment of Marketing Authorization Application for Xilonix(TM), XBiotech’s True Human(TM) Therapeutic Antibody Treatment for Advanced Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Apr 2016
Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Asian Patients with Refractory Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Mar 2016
SIR-Spheres(R) Y-90 Resin Microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says
Devices Oncology
 HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2016
Debiopharm International SA Has Won Its Patent Infringement Suit for Elplat(R) Against Nippon Kayaku Co., Ltd.
Biopharmaceuticals Generics Oncology Litigation
 HSMN NewsFeed - 29 Feb 2016
CHMP Issues Positive Opinion for LONSURF(R) (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 25 Feb 2016
Anthem BCBS Georgia and Virginia Contracted to Cover Cologuard as In-Network Service
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 23 Feb 2016
SIRFLOX Study Published in Journal of Clinical Oncology
Devices Interventional Radiology Oncology
 HSMN NewsFeed - 11 Feb 2016
Incyte Announces Decision to Discontinue JANUS Studies of Ruxolitinib plus Capecitabine in Patients with Advanced or Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jan 2016
Exact Sciences Announces Appointment of John A. Fallon, M.D., to Company's Board of Directors
Diagnostics Oncology Personnel
 HSMN NewsFeed - 25 Jan 2016
Boston Biomedical's Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured at the ASCO 2016 Gastrointestinal Cancers Symposium
Biopharmaceuticals Oncology Gastroenterology
 HSMN NewsFeed - 19 Jan 2016
Thetis Receives Orphan Drug Designation for TP-252 in Familial Adenomatous Polyposis
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jan 2016
Dr. Rolf Muller Appointed as New CEO of BioFluidica, Inc.
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jan 2016
Origin Sciences Secures North American Distributor
Devices Diagnostics Distribution
 HSMN NewsFeed - 18 Dec 2015
European Commission Approves Amgen's IMLYGIC(TM) (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Dec 2015
Ignyta Receives Orphan Drug Designation in the European Union for Entrectinib for the Treatment of Neuroblastoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Oct 2015
Biothera Appoints Dr. Jose Iglesias as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2015
Uptake Medical Announces First-in-Human Lung Cancer Tumor Ablation Using Intervapor(R) Targeted Vapor Therapy
Devices Oncology
 HSMN NewsFeed - 6 Oct 2015
Exelixis Announces Positive Overall Survival Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma
Biopharmaceuticals Oncology Dermatology
 HSMN NewsFeed - 10 Sep 2015
iCAD Announces Appointment of Two Vice Presidents to Lead Cancer Detection Sales and Marketing Teams
Devices Oncology Personnel
 HSMN NewsFeed - 24 Aug 2015
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Aug 2015
Immunomedics Appoints Arthur S. Kirsch as Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Aug 2015
Check-Cap Announces Appointment of William Densel as Chief Executive Officer and Director
Diagnostics Oncology Personnel
 HSMN NewsFeed - 13 Aug 2015
Sirtex Medical Inc. Announces 21.2 Percent Dose Sales Growth of SIR-Spheres(R) Y-90 resin microspheres in Fourth Quarter
Devices Oncology Interventional
 HSMN NewsFeed - 20 Jul 2015
Applied Proteomics Appoints Robert C. Verfurth as Vice President, Sales
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 29 May 2015
Transgenomic Launches EGFR CLIA Test That Accurately Detects Key Mutations in Solid and Liquid Patient Samples Using Multiplexed ICE COLD-PCR(TM)
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 11 May 2015
Roche Receives FDA Approval for cobas(R) KRAS Mutation Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 6 Apr 2015
European Commission Approves Amgen's Vectibix(R) (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Mar 2015
EDP Biotech Signs Distribution Partnership Agreements for ColoMarker(R) Abroad
Diagnostics Oncology Distribution
 HSMN NewsFeed - 17 Mar 2015
Sirtex Reports Preliminary SIRFLOX Study Results
Devices Drug Delivery Oncology
 HSMN NewsFeed - 26 Feb 2015
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 19 Feb 2015
FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jan 2015
Regeneron and Sanofi Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jan 2015
Exact Sciences: Additional Update on CMS Reimbursement for Cologuard(R)
Diagnostics Reimbursement
 HSMN NewsFeed - 17 Oct 2014
EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 22 Sep 2014
Regeneron Announces EYLEA(R) (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 3 Sep 2014
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Aug 2014
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Aug 2014
FDA Approves Exact Sciences' Cologuard(R); First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 11 Aug 2014
Mylan Launches Generic Xeloda(R) Tablets
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 5 Aug 2014
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery
Devices Neurosurgery Oncology
 HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Jul 2014
Genentech’s Investigational Medicine Cobimetinib, Used in Combination with Zelboraf(R) (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 May 2014
IsoRay's Liquid Cesium-131 (Cesitrex(R)) Recieves Final Regulatory Approval for Use in GliaSite(R) Brain Cancer Treatment System
Devices Oncology Regulatory
 HSMN NewsFeed - 1 May 2014
Merrimack Pharmaceuticals Announces MM-398 Achieves Primary Endpoint of Overall Survival in Phase 3 Trial in Post-Gemcitabine Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Mar 2014
New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Mar 2014
Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Mar 2014
Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Mar 2014
Exact Sciences Announces Appointment of Kevin Conroy as Chairman of the Board; David Thompson to Serve as Lead Independent Director
Diagnostics Oncology Personnel
 HSMN NewsFeed - 19 Mar 2014
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
Devices Oncology
 HSMN NewsFeed - 26 Feb 2014
Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy Testing for Colorectal Cancer
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2014
iCAD Appoints Dr. Robert Goodman to Board of Directors
Devices Radiology Oncology Personnel
 HSMN NewsFeed - 20 Feb 2014
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Feb 2014
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Feb 2014
AVEO and Astellas to End Worldwide Collaboration & License Agreement for Development and Commercialization of Tivozanib
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 Feb 2014
Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy
Devices Gastroenterology FDA
 HSMN NewsFeed - 29 Jan 2014
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
Diagnostics Oncology
 HSMN NewsFeed - 27 Jan 2014
Biothera Names VP of Biomarker Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 23 Dec 2013
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Dec 2013
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Dec 2013
Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 10 Dec 2013
FDA Grants Fast Track Designation to Navidea Biopharmaceuticals’ Lymphoseek(R) for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 4 Dec 2013
SMART Medical Systems Announces Strategic Alliance with PENTAX Medical in the EMEA Countries, Aimed to Improve Patient Care in Colonoscopy
Devices Gastroenterology
 HSMN NewsFeed - 27 Nov 2013
PENTAX Medical and SMART Medical Systems Announce Strategic Pan-European Alliance That Will Change the Standard of Care in Colonoscopy
Devices Gastroenterology
 HSMN NewsFeed - 22 Nov 2013
EYLEA(R) (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 22 Nov 2013
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
Biopharmaceuticals
 HSMN NewsFeed - 19 Nov 2013
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 24 Oct 2013
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
Diagnostics Oncology
 HSMN NewsFeed - 17 Oct 2013
Health Canada Approves A New Treatment Option For Patients With Gastrointestinal Stromal Tumours (GIST), A Rare Form Of Sarcoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Oct 2013
IntegraGen Obtains Exclusive License for MicroRNA Which Predicts Therapy Outcomes in Metastatic Colorectal Cancer
Diagnostics Oncology Licensing
 HSMN NewsFeed - 14 Oct 2013
Multiple New Studies Discuss Clinical Benefits of Given Imaging's PillCam(R) COLON at United European Gastroenterology Week
Devices Gastroenterology
 HSMN NewsFeed - 5 Sep 2013
Myriad Genetics Launches myRisk(TM) Hereditary Cancer Panel
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 30 Aug 2013
Bayer's Stivarga(R) (regorafenib) Tablets Approved in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 20 Aug 2013
Applied Proteomics Inc. Completes $28 Million Series C Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 30 Jul 2013
TheraSphere(R) Recommended by the National Institute for Health and Care Excellence (NICE) for the Treatment of Primary and Secondary Liver Cancer
Devices Oncology
 HSMN NewsFeed - 26 Jul 2013
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 24 Jul 2013
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Jul 2013
GeneNews Announces Management and Board Changes
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 15 Jul 2013
Given Imaging's PillCam(R) COLON Cleared in Japan, World's Second Largest Healthcare Market
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 13 Jun 2013
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 30 May 2013
SIR-Spheres(R) microspheres as Effective and Safe in the Elderly as they are in Younger Patients with Colorectal Liver Metastases According to Data Released at ASCO Annual Meeting
Devices Drug Delivery Oncology
 HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2013
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
Biopharmaceuticals
 HSMN NewsFeed - 3 May 2013
iCAD’s Xoft Intraoperative Radiation Therapy System Featured at American Society of Breast Surgeons Conference
Devices Surgery Oncology
 HSMN NewsFeed - 10 Apr 2013
SpectraScience and PENTAX Medical Announce Expanded Distribution of WavSTAT4 Optical Biopsy System in Europe
Devices Oncology Distribution
 HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Feb 2013
Alchemia Appoints Charles Walker as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2013
ZALTRAP(R) (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Jan 2013
Spectrum Pharmaceuticals Announces Promotion of Joseph Turgeon to Senior Vice President and Chief Commercial Officer as Company Builds on Recent Commercial Reorganization to Advance Growth and Market Penetration over the Next Five Years
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2013
Gradalis, Inc. Closes $24 Million in Series B Financing to Advance Late-Stage Trials of FANG(TM) Personalized Cancer Vaccine
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Dec 2012
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Dec 2012
IsoRay's Cesium-131 Seeds Proves Successful for Brain Cancer Treatment as Presented by Weill Cornell and Barrow Neurological to The Society Of Neuro-Oncology
Devices Oncology
 HSMN NewsFeed - 11 Dec 2012
Sirtex Medical Limited Launches New Global Website for SIR-Spheres(R) Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours
Devices Oncology
 HSMN NewsFeed - 27 Nov 2012
Given Imaging Submits PillCam(R) COLON 2 Application to FDA for U.S. Regulatory Clearance
Devices Gastroenterology FDA
 HSMN NewsFeed - 5 Nov 2012
iCAD Reports Significantly Improved Medicare Payment for Intraoperative Radiation Therapy
Devices Oncology Reimbursement
 HSMN NewsFeed - 29 Oct 2012
Bayer's Stivarga(R) (regorafenib) Tablets New Drug Application Granted Priority Review by U.S. FDA for the Treatment of Patients with Gastrointestinal Stromal Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Oct 2012
IsoRay's Brain and Lung Cancer Products Showcased at the American Society for Radiation Oncology (ASTRO) Convention
Devices Oncology
 HSMN NewsFeed - 29 Oct 2012
iCAD Reports Growing Adoption of Its Xoft Electronic Brachytherapy System by Leading U.S. Regional Hospitals
Devices Oncology
 HSMN NewsFeed - 29 Oct 2012
Sagent Pharmaceuticals Announces the Launch of Leucovorin Calcium for Injection
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Sep 2012
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Aug 2012
Sirtex Medical Inc. Expands U.S. Operations to Accommodate Increased Demand for SIR-Spheres Microspheres
Devices Oncology
 HSMN NewsFeed - 15 Aug 2012
Spectrum Pharmaceuticals Launches a Broad-based FUSILEV(R) Marketing Campaign; Increases Sales Force Footprint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Aug 2012
Genentech Study Showed That Adding Avastin to Radiation and Chemotherapy Significantly Extended the Time People with an Aggressive Form of Brain Cancer Lived without Their Disease Worsening
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Aug 2012
Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin Injection
Biopharmaceuticals Generics Oncology
 HSMN NewsFeed - 25 Jul 2012
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
Diagnostics Oncology Personalized Medicine Personnel
 HSMN NewsFeed - 2 Jul 2012
Journal of the American College of Surgeons Publishes Study on Using the NanoKnife(R) System to Treat Liver Tumors Adjacent to Blood Vessels
Devices Surgery Oncology
 HSMN NewsFeed - 5 Jun 2012
IsoRay Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors
Devices Neurosurgery Oncology
 HSMN NewsFeed - 4 Jun 2012
Phase 3 Data on Regorafenib Met Primary Endpoint Showing Significant Improvement in Progression-Free Survival in Patients with GIST
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2012
Phase III Data on Bayer's Regorafenib Met Primary Endpoint Showing Significant Improvement in Progression-Free Survival in Patients with GIST
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2012
New Studies Confirm Given Imaging's PillCam(R) COLON 2's Feasibility in an Outpatient Setting
Devices Gastroenterology
 HSMN NewsFeed - 22 May 2012
IsoRay’s GliaSite Approved for Sale in 31 European Countries
Devices Oncology Regulatory
 HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 May 2012
IsoRay to Introduce GliaSite and Cesium-131 Mesh to International Audience at World Congress of Brachytherapy
Devices Oncology
 HSMN NewsFeed - 4 May 2012
Breastlink Medical Group to Offer iCAD’s Xoft Radiation Therapy System to Breast Cancer Patients
Devices Oncology
 HSMN NewsFeed - 3 May 2012
Pink Lotus Breast Center to Launch IORT Program Featuring iCAD’s Xoft Radiation Therapy System for Breast Cancer Patients
Devices Oncology
 HSMN NewsFeed - 24 Apr 2012
Nordion Announces Europe-Focused Phase III Clinical Trial for TheraSphere(R) Liver Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
Diagnostics FDA
 HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Biopharmaceuticals
 HSMN NewsFeed - 23 Mar 2012
Largest Comparative Study of Radioembolisation Shows SIR-Spheres Microspheres Significantly Improves Survival for Cancer Patients with Inoperable Liver Tumours
Devices Oncology
 HSMN NewsFeed - 14 Mar 2012
Everist Genomics Develops World's First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 12 Mar 2012
Synta Announces Appointment of Dvorit Samid, Ph.D., as Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2012
Dainippon Sumitomo Pharma Co., Ltd. to Acquire Boston Biomedical, Inc. for up to $2.63 Billion; Acquisition Includes a World-Leading Pipeline Targeting Cancer Stem Cells
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2012
Study Published in Molecular Therapy Shows that Immune Response to FANG(TM) Personalized Cancer Therapeutic Correlates with Prolonged Survival in Patients with Advanced Stage Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Feb 2012
invendo medical Announces 510(k) Clearance by FDA for Advancement-Assisted Single-Use Colonoscopy System
Devices Gastroenterology FDA
 HSMN NewsFeed - 17 Feb 2012
Threshold Pharmaceuticals Appoints Dr. Tillman Pearce as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2012
Delcath Appoints Industry Veteran Chris Houchins as Senior Vice President of Clinical and Medical Affairs
Devices Drug Delivery Personnel
 HSMN NewsFeed - 1 Feb 2012
Dendreon Announces CEO and Chairman Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2012
Spectrum Pharmaceuticals Strengthens Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2012
Given Imaging Provides Update on PillCam(R) COLON 2 Pivotal Trial Enrollment
Devices Gastroenterology
 HSMN NewsFeed - 22 Nov 2011
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 15 Nov 2011
Given Imaging Initiates Pivotal Trial for PillCam(R) COLON 2 in Japan
Devices Gastroenterology
 HSMN NewsFeed - 3 Nov 2011
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
Devices Oncology Distribution
 HSMN NewsFeed - 26 Oct 2011
Phase III Trial of Bayer's Investigational Compound Regorafenib (BAY 73-4506) in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Sep 2011
Covidien Announces New Data That Demonstrate Superior Performance of Its iDrive(TM) Powered Handle and Right Angle Linear Cutter in Open Colorectal Surgery
Devices Surgery
 HSMN NewsFeed - 6 Sep 2011
Regeneron Announces Appointment of Joseph J. LaRosa as Senior Vice President, General Counsel and Secretary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2011
ZIOPHARM Oncology Appoints Hagop Youssoufian, M.Sc., M.D., as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jun 2011
iCAD’s VeraLook(R) for CT Colonography Now Available with Vital Images’ Products
Devices Radiology Oncology Gastroenterology
 HSMN NewsFeed - 13 Jun 2011
Spectrum Pharmaceuticals Announces Promotions of Steven M. Fruchtman, MD, to Chief Medical Officer, Head of Medical & Regulatory Affairs, and Nozar Azarnia, PhD, to Head of Biostatistics and Data Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2011
Given Imaging Initiates 800-Patient Multi-Center, Pivotal Trial for PillCam(R) COLON 2
Devices Gastroenterology
 HSMN NewsFeed - 6 Jun 2011
ZALTRAP (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2011
Fox Chase Cancer Center Study Evaluating the Safety of Concurrent Chemotherapy and Selective Internal Radiation Therapy using SIR-Spheres(R) Microspheres Released at 2011 American Society of Clinical Oncology Annual Meeting
Devices Oncology
 HSMN NewsFeed - 2 Jun 2011
Galectin Therapeutics Announces the Appointment of Kevin Freeman and John Mauldin to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2011
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Mar 2011
APP Pharmaceuticals Issues a Nationwide Voluntary Recall of Irinotecan Hydrochloride Injection
Biopharmaceuticals Oncology Product Recall
 HSMN NewsFeed - 18 Mar 2011
Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Mar 2011
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2011
Biothera Acquires MUC1 Anti-Cancer Monoclonal Antibody From Antisoma
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 9 Mar 2011
Pro-Pharmaceuticals Names Peter G. Traber, M.D., Former GlaxoSmithKline Chief Medical Officer & President Emeritus of Baylor College of Medicine, President & Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2011
New Study Published in Gastrointestinal Endoscopy Confirms Third Eye(R) Retroscope(R) Improves Detection of Pre-Cancerous Polyps During Colonoscopy
Devices Gastroenterology Oncology
 HSMN NewsFeed - 24 Feb 2011
FDA Grants Genentech a Hearing on Avastin’s Use for Metastatic Breast Cancer in the United States
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Feb 2011
Given Imaging's PillCam(R) COLON Now Reimbursable for Hospital Inpatient Use in Germany
Devices Gastroenterology Reimbursement
 HSMN NewsFeed - 8 Feb 2011
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jan 2011
Radient Pharmaceuticals Receives Updated European Union Certification for Onko-Sure(R); CE Mark Opens Large Market for Company's IVD Cancer Test
Diagnostics Regulatory
 HSMN NewsFeed - 18 Jan 2011
Diagnoplex Closes an Extension of its Series A Financing With a Substantial Investment by Debiopharm Group(TM)
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 10 Jan 2011
Celator(R) Pharmaceuticals and Cephalon, Inc. Agree to Extend Research Agreement into Next Phase of Development
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jan 2011
U.S. Food and Drug Administration (FDA) Clears Novel ImageSense(TM) Technology for Use with Colposcopy
Devices Oncology FDA
 HSMN NewsFeed - 5 Jan 2011
Given Imaging Provides PillCam(R) COLON 2 Update
Devices Gastroenterology
 HSMN NewsFeed - 16 Dec 2010
Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Nov 2010
Neogenix Oncology(R) Receives FDA Orphan Drug Status for Ensituximab (NPC-1C) for Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Oct 2010
AspenBio Advances AppyScore(TM) Cassette-Based Test and Adds Regulatory and Sales and Marketing Expertise
Diagnostics Personnel
 HSMN NewsFeed - 20 Sep 2010
Celera Signs Agreement with Abbott for Distribution of CE-marked KIF6 Test to Identify Patients at Risk of Coronary Heart Disease
Diagnostics Cardiology Distribution
 HSMN NewsFeed - 13 Sep 2010
AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2010
Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Sep 2010
Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Aug 2010
iCAD Announces FDA Clearance of the Company's Computer-Aided Detection Product for Virtual Colonoscopy
Devices Radiology Gastroenterology FDA
 HSMN NewsFeed - 29 Jul 2010
Calistoga Pharmaceuticals Appoints Langdon L. Miller, M.D., Executive Vice President, Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2010
GE Launches Study to Improve Diagnosis of Early Stage Colon Cancer
Diagnostics Oncology
 HSMN NewsFeed - 21 Jul 2010
Radient Pharmaceuticals Announces Exclusive Distribution Agreement With AMDL Australia Pty Ltd.
Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 21 Jul 2010
Keryx Biopharmaceuticals, Inc. Announces Appointment of Joseph Feczko, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2010
Radient Pharmaceuticals Appoints Dr. Robert Beart Jr. MD to RPC's Board of Directors
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 14 Jul 2010
Aeterna Zentaris Announces Perifosine Has Received Orphan-Drug Designation for the Treatment of Neuroblastoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Jul 2010
Radient Pharmaceuticals Enters Into a Letter of Intent to Acquire Provista Diagnostics Inc.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 1 Jul 2010
BioVex Appoints Steven Kelly as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2010
Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jun 2010
ADVENTRX Grants Exclusive Worldwide Rights to CoFactor Know-How and Data
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 May 2010
Takeda to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 May 2010
Ethicon Endo-Surgery SEDASYS(R) System Receives Regulatory Approval in Canada and CE Mark in European Union
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 23 Apr 2010
Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Apr 2010
Aeterna Zentaris Announces Initiation of Phase 3 Registration Trial with Perifosine in Refractory Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Apr 2010
Par Pharmaceutical Enters Into Agreement With sanofi-aventis to Settle Patent Litigation Over Generic Eloxatin(R)
Biopharmaceuticals Generics Oncology Litigation
 HSMN NewsFeed - 5 Apr 2010
Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Refractory Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Mar 2010
Pro-Pharmaceuticals Licenses to PROCAPS S.A. Exclusive Marketing and Distribution Rights to Commercialize DAVANAT(R) to Treat Cancer in Colombia, South America
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 29 Mar 2010
Merck Serono: Erbitux Granted Extended Use in Japan for 1st-Line Treatment of mCRC Patients with KRAS Wild-Type Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Mar 2010
Asuragen Appoints French Distributor Biomedical Diagnostics SA for Signature(R) Oncology Portfolio
Diagnostics Oncology Distribution
 HSMN NewsFeed - 16 Mar 2010
NCCN Guidelines Expand Their Reach to Japan
Oncology
 HSMN NewsFeed - 5 Mar 2010
Saladax Biomedical Closes $8 Million Series C Financing
Personalized Medicine Diagnostics Venture Capital
 HSMN NewsFeed - 3 Mar 2010
Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Mar 2010
AEterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for Perifosine for the Treatment of Multiple Myeloma from the Committee for Orphan Medicinal Products of the European Medicines Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Feb 2010
Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jan 2010
Spectrum Pharmaceuticals Announces Results of FDA Meeting Regarding FUSILEV(R) sNDA under Review for Advanced Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jan 2010
Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jan 2010
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
Devices Oncology
 HSMN NewsFeed - 19 Jan 2010
Sirtex Appoints Michael Mangano to Lead U.S. Operations
Devices Oncology Personnel
 HSMN NewsFeed - 17 Dec 2009
NiTi Surgical Solutions Announces First Application of ColonRing in China
Devices Gastroenterology Surgery
 HSMN NewsFeed - 14 Dec 2009
Dennis Winger Joins Nektar Therapeutics' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2009
Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Nov 2009
Given Imaging Launches Next-Generation PillCam(R) COLON 2 at GASTRO 2009 Conference
Devices Gastroenterology
 HSMN NewsFeed - 19 Nov 2009
Delcath Systems Reports Substantial Progress
Devices Oncology
 HSMN NewsFeed - 5 Nov 2009
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Sep 2009
Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Sep 2009
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Sep 2009
Data Presented from Two Phase 3 ERBITUX(R) Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Sep 2009
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Aug 2009
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Aug 2009
Teva Announces Approval and Launch of Oxaliplatin Injection
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 11 Aug 2009
Hospira Launches Generic Oxaliplatin Injection
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 3 Aug 2009
FDA Approves Avastin for the Most Common Type of Kidney Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Jul 2009
Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jul 2009
ImClone Systems and Bristol-Myers Squibb Announce Revisions to ERBITUX(R) (cetuximab) U.S. Product Labeling for Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Jun 2009
Sutent Significantly Improved Progression-Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Jun 2009
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2009
Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2009
Randomized Controlled Trial of Radioactive Resin Microspheres Demonstrates Significant Delay in Progression of Disease in Patients with Colorectal Cancer Liver Metastases who have Exhausted Chemotherapy
Biopharmaceuticals Oncology Gastroenterology
 HSMN NewsFeed - 1 Jun 2009
Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2009
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 May 2009
FDA Grants Accelerated Approval of Avastin for Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 May 2009
NiTi Surgical Solutions Announces U.S. Launch of Revolutionary ColonRing Surgical Device at ASCRS Annual Meeting
Devices Surgery
 HSMN NewsFeed - 27 Apr 2009
InfuSystem Appoints Bryan Russo as Chief Commercial Officer
Devices Personnel
 HSMN NewsFeed - 22 Apr 2009
Immunomedics Reports Results That Could Expand Use of Milatuzumab in Cancer Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Apr 2009
Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Apr 2009
Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment
Biopharmaceuticals Oncology Generics Litigation
 HSMN NewsFeed - 2 Apr 2009
Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Advanced Breast Cancer Trials Continue
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2009
Sutent Significantly Increases Progression Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors, Study Stopped Early
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Mar 2009
ImClone Systems and Bristol-Myers Squibb Update Status of First-Line Squamous Cell Carcinoma of the Head and Neck Supplemental Biologics Application for ERBITUX(R) in U.S.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Feb 2009
Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon
Devices Gastroenterology FDA
 HSMN NewsFeed - 3 Feb 2009
Warnex Offers New Personalized Medicine Service: K-ras Mutation Analysis for Colorectal Cancer
Diagnostics Oncology
 HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2009
FDA Provides Clear Path to NDA Submission for Pro-Pharmaceuticals’ DAVANAT(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jan 2009
ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics Application Submission for ERBITUX(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Jan 2009
Avantis Medical Systems, Inc. Raises $10 Million in Series C Funding
Devices Gastroenterology Oncology Venture Capital
 HSMN NewsFeed - 16 Jan 2009
New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Dec 2008
Myriad Genetics Launches Sixth Personalized Medicine Product, Prezeon -- to Reveal PTEN Status
Diagnostics Oncology
 HSMN NewsFeed - 11 Dec 2008
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2008
Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 24 Nov 2008
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Nov 2008
Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Nov 2008
Medicsight Seeks FDA 510(k) Clearance to Market its ColonCAD(TM) Software in the U.S.
Devices Radiology Oncology FDA
 HSMN NewsFeed - 3 Nov 2008
Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2008
NCCN Updates Guidelines for Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2008
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Oct 2008
Spectrum Pharmaceuticals Files Supplemental New Drug Application with FDA for FUSILEV(TM) in Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2008
Study Published in New England Journal of Medicine Shows K-ras Gene Mutation Status May Affect Response to ERBITUX(R) Treatment
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2008
Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Oct 2008
Study Presented at UEGW International Conference Shows That New Device Significantly Improves Visualization of the Colon
Devices Gastroenterology
 HSMN NewsFeed - 20 Oct 2008
PillCam(R) COLON Shows Substantial Agreement With Gold Standard Colonoscopy in Detection of Ulcerative Colitis
Devices Gastroenterology
 HSMN NewsFeed - 20 Oct 2008
Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Oct 2008
Predictive Biosciences Closes $21.75 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 6 Oct 2008
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Sep 2008
Philips Showcases Comprehensive, Integrated Oncology Suite at ASTRO
Devices Oncology
 HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2008
New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2008
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Aug 2008
DiagnoCure receives approval from the U.S. regulatory authorities and launches its Previstage(TM) GCC Colorectal Cancer Staging Test
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 15 Aug 2008
Spectrum Pharmaceuticals Launches FUSILEV(TM)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Aug 2008
EXACT Sciences Announces Next Generation Stool-based DNA Technology Study Results of 92% for Colorectal Cancer Detection
Diagnostics Gastroenterology Oncology
 HSMN NewsFeed - 5 Aug 2008
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 31 Jul 2008
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Jul 2008
Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Jul 2008
Light Sciences Oncology Raises $40.1 Million in Series C Financing
Devices Oncology Venture Capital
 HSMN NewsFeed - 14 Jul 2008
LabCorp Announces Availability of ColoSure(TM)
Diagnostics Oncology
 HSMN NewsFeed - 14 Jul 2008
ImClone Announces Changes in Commercial Organization Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2008
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 7 Jul 2008
Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
Devices Urology
 HSMN NewsFeed - 1 Jul 2008
Clarient Launches New Colorectal Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 16 Jun 2008
IRX Therapeutics Names Scott M. Freeman, M.D. Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2008
New Drug Application Filing for Levoleucovorin Tablets Completed by Spectrum Pharmaceuticals, Inc.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Jun 2008
ImClone Appoints Dr. Bernhard Ehmer Senior Vice President and Managing Director, International Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2008
New Analyses of Pivotal Phase 3 Study of ERBITUX(R) Demonstrate Enhanced Efficacy in First-Line Metastatic Colorectal Cancer Patients with Wild-Type K-Ras Biomarker
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2008
Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Premenopausal Women With Early-Stage Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Amgen Presents New Data at ASCO on Four Investigational Molecules from Oncology Pipeline
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2008
Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2008
DiagnoCure Oncology Laboratories introduces Previstage GCC, the First Molecular Colorectal Cancer Staging Test - Company Hires Specialty Sales Force
Diagnostics Oncology
 HSMN NewsFeed - 28 May 2008
New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 May 2008
Sirtex Launches Global Clinical Trial Comparing the Use of SIR-Spheres(R) Microspheres Plus Chemotherapy versus Chemotherapy Alone as First Line Treatment for Metastatic Colorectal Cancer
Devices Oncology
 HSMN NewsFeed - 21 May 2008
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 May 2008
Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 May 2008
ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 May 2008
Sirtex Sponsors Pilot Study Evaluating SIR-Spheres(R) Microspheres for the Treatment of Unresectable Hepatocelluar Carcinoma
Devices Interventional Oncology
 HSMN NewsFeed - 9 May 2008
Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2008
SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
Devices Gastroenterology Distribution
 HSMN NewsFeed - 23 Apr 2008
MacroChem Acquires Virium Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Apr 2008
Genentech Provides Update on ''AVAiL'' Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2008
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Apr 2008
PEAK Surgical Names John Cifarelli Vice President, Sales
Devices Personnel
 HSMN NewsFeed - 1 Apr 2008
DiagnoCure provides update on operations
Diagnostics
 HSMN NewsFeed - 27 Mar 2008
Ethicon Endo-Surgery Submits Application to FDA for Approval of the SEDASYS(TM) System - the First Computer-Assisted Personalized Sedation System
Devices Drug Delivery Gastroenterology FDA
 HSMN NewsFeed - 24 Mar 2008
Sirtex Announces New President for U.S. Operations
Devices Personnel
 HSMN NewsFeed - 24 Mar 2008
Pro-Pharmaceuticals Announces DAVANAT(R) Regimen Approved to Treat Breast Cancer Patient
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Mar 2008
Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2008
Immunomedics Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Mar 2008
Dynavax and Merck & Co., Inc. Report Clinical Hold of Investigational Vaccine HEPLISAV
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2008
Genentech Provides Business Update at Annual Investment Community Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Mar 2008
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Mar 2008
Colorectal Cancer Screening Guidelines Released by the American Cancer Society Include EXACT Sciences' Stool DNA Technology
Diagnostics Oncology
 HSMN NewsFeed - 3 Mar 2008
Pro-Pharmaceuticals DAVANAT(R) Extends Median Survival 6.7 Months for End-Stage Colorectal Cancer Patients After All Other Treatments Failed
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Feb 2008
APP Pharmaceuticals Receives Final Approval for Irinotecan Hydrochloride Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Feb 2008
FDA Clears Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients
Diagnostics FDA
 HSMN NewsFeed - 22 Feb 2008
FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Feb 2008
Given Imaging Announces PillCam(R) COLON Approval in Israel
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 19 Feb 2008
Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer
Diagnostics Oncology Licensing
 HSMN NewsFeed - 11 Feb 2008
New Data Shows DAVANAT(R) Extends Survival of End-Stage Colorectal Cancer Patients More Than 6 Months
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Feb 2008
Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2008
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Jan 2008
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Jan 2008
KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy and Patient Reported Outcomes in Advanced Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Jan 2008
EXACT Sciences Schedules Meeting with CMS to Discuss Application for National Coverage of Stool-based DNA Colorectal Cancer Screening
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 14 Jan 2008
Joseph A. Mollica Named Chairman of Celator(R) Pharmaceuticals Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2008
Xeloda(R) Combination Therapy in Esophagogastric Cancer Highlighted in New England Journal of Medicine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jan 2008
Delcath Appoints Three Leading Physicians to Its Newly Formed Scientific Advisory Board
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 19 Dec 2007
Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Dec 2007
Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Dec 2007
Genentech Provides Update from Avastin FDA Advisory Meeting
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Dec 2007
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Dec 2007
DiagnoCure establishes U.S. commercial operations - Lease signed on service laboratory and key directors hired
Diagnostics Personnel
 HSMN NewsFeed - 3 Dec 2007
Immunicon Corporation Announced the Filing for FDA Clearance of the CellSearch(TM) Circulating Tumor Cell Kit for Monitoring Patients with Metastatic Androgen-Independent Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 29 Nov 2007
Published Data Suggest That ERBITUX(R) Enables Complete Surgical Resection of Colorectal Liver Metastases in Patients Previously Refractory to Conventional Systemic Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Nov 2007
CellSearch(TM) Circulating Tumor Cell Kit Receives FDA Clearance for Monitoring Patients with Metastatic Colorectal Cancer
Diagnostics FDA
 HSMN NewsFeed - 18 Nov 2007
Avastin Shows Encouraging Results in Phase II Study in Patients With the Most Aggressive Form of Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Nov 2007
NCCN Receives Major Grant for Anti-Cancer Drug Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Nov 2007
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Nov 2007
AngioDynamics Highlights Study Showing Significant 5-Year Survival After Ablation of Colorectal Liver Metastases
Devices Oncology
 HSMN NewsFeed - 7 Nov 2007
DiagnoCure Furthers Development of Diagnostic Pipeline
Diagnostics Oncology
 HSMN NewsFeed - 2 Nov 2007
ADVENTRX Provides Update on Cofactor(R) Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Nov 2007
Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
Biopharmaceuticals
 HSMN NewsFeed - 29 Oct 2007
Given Imaging Announces Clinical Data Presented During United European Gastroenterology Week
Devices Gastroenterology
 HSMN NewsFeed - 17 Oct 2007
Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
Oncology
 HSMN NewsFeed - 17 Oct 2007
Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Oct 2007
ImClone and Bristol-Myers Squibb Announce Joint Agreement with Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Oct 2007
AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
Diagnostics Oncology
 HSMN NewsFeed - 3 Oct 2007
Alethia Biotherapeutics Inc. Announces in-Licensing of Family of Monoclonal Antibodies to Treat Metastatic Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 2 Oct 2007
Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Sep 2007
NeoGuide Systems Appoints John Cifarelli to Vice President of Sales
Devices Personnel
 HSMN NewsFeed - 25 Sep 2007
New Biomarker Data Links KRAS Gene to Vectibix(TM) Clinical Response
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Sep 2007
Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2007
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Sep 2007
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2007
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2007
HAPC Announces Purchase Price Reduction for InfuSystem Acquisition
Devices Mergers & Acquisitions
 HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
Biopharmaceuticals Oncology Litigation Licensing
 HSMN NewsFeed - 7 Sep 2007
Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Sep 2007
Pfizer Oncology Initiates Global Phase III Trial to Evaluate Sunitinib Malate Combined with Erlotinib in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Sep 2007
Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Sep 2007
Roche's Tarceva(R) Delivers Longer Life for Lung Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Sep 2007
Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Aug 2007
YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Aug 2007
Genentech Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel for First-Line Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Aug 2007
GlaxoSmithKline Accelerates Review of Exelixis' XL880
Biopharmaceuticals
 HSMN NewsFeed - 16 Aug 2007
ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Aug 2007
Oncoscience Ag, the European Partner of Ym Biosciences, Announces Completion of Patient Enrollment in Phase III Brain Cancer Trial of Nimotuzumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Aug 2007
Review Examines the Use of Sirtex's SIR-Spheres(R) Microspheres in Patients with Hepatic Colorectal Cancer Metastases
Devices Oncology
 HSMN NewsFeed - 7 Aug 2007
Siemens syngo(R) Colonography PEV for CT Colonography Examinations - A New Level of Effectiveness
Devices Radiology
 HSMN NewsFeed - 7 Aug 2007
NeoGuide Systems Names Jim Talbot Vice President, Quality and Regulatory Affairs
Devices Personnel
 HSMN NewsFeed - 2 Aug 2007
Celator Closes $10 Million Follow-On Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jul 2007
Light Sciences Oncology Initiates Phase III Trial of Its Light Infusion Therapy (Litx(TM)) in Patients with Metastatic Colorectal Cancer
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 17 Jul 2007
Aventir Biotech Launches New 510(k) Cleared Fecal Occult Blood Screen Test
Diagnostics FDA
 HSMN NewsFeed - 12 Jul 2007
Sirtex Announces New Medical Director for U.S. Operations
Devices Oncology Personnel
 HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jul 2007
EXACT Sciences' DNA Technology is Preferred Non-Invasive Method for Colorectal Cancer Screening Among Patients
Diagnostics Oncology
 HSMN NewsFeed - 11 Jul 2007
Spectrum Strengthens Management With the Appointment of George Uy, an Industry Veteran, as Vice President, Marketing Oncology/Urology
Biopharmaceuticals Oncology Urology Personnel
 HSMN NewsFeed - 9 Jul 2007
Pro-Pharmaceuticals Updates Progress of Clinical Trials & DAVANAT(R) 505 (b)(2) Filings
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 28 Jun 2007
Coley Pharmaceutical Group Grants Dynavax License for Commercialization of HEPLISAV(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 Jun 2007
Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jun 2007
GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 20 Jun 2007
Plexxikon Expands Management Team and Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2007
Toshiba to Sponsor Harvard Medical School Course in Virtual Colonoscopy
Devices Radiology Gastroenterology
 HSMN NewsFeed - 19 Jun 2007
Abraxis BioScience Exclusively Licenses Intellectual Property Portfolio Designed to Personalize Treatment for Colorectal Cancer from the University of Southern California
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Jun 2007
OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Jun 2007
Health Canada approves new chemotherapy treatment for patients with metastatic colorectal cancer
Biopharmaceuticals Oncology Regulatory
Return to NewsFeed  

 Additional items found! 382

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 382 additional stories matching:
Colorectal Cancer
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.